» Articles » PMID: 27746178

MicroRNA-1297 Inhibits Prostate Cancer Cell Proliferation and Invasion by Targeting the AEG-1/Wnt Signaling Pathway

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2016 Oct 18
PMID 27746178
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) have been known to be implicated in tumorigenic programs. miR-1297 has been reported to be dysregulated and involved in cancer progression in many types of human cancers. However, the expression level and the role of miR-1297 in prostate cancer remain unclear. Herein, we aimed to investigate the potential role and molecular mechanism of miR-1297 in prostate cancer progression. We found that miR-1297 was significantly downregulated in human prostate cancer specimens as well as in several prostate cancer cell lines. In addition, functional experiments demonstrated that overexpression of miR-1297 remarkably inhibited prostate cancer cell proliferation and invasion whereas miR-1297 suppression significantly promoted prostate cancer cell proliferation and invasion. Bioinformatics analysis showed that the Astrocyte elevated gene-1 (AEG-1), a well-known oncogene, is a predicted target of miR-1297. Dual-luciferase reporter assay showed that miR-1297 was able to directly target the 3'-untranslated region of AEG-1. In addition, RT-qPCR and Western blot analysis showed that miR-1297 regulated the mRNA and protein expression levels of AEG-1. We also showed that miR-1297 was able to regulate the Wnt signaling pathway. Moreover, rescue assays indicated that AEG-1 contributed to miR-1297-endowed effects on cell proliferation and invasion as well as Wnt signaling pathway. Taken together, these findings suggest that miR-1297 inhibits prostate cancer proliferation and invasion by targeting AEG-1, thereby providing novel insight into understanding the pathogenesis of prostate cancer. Thus, miR-1297 may be a novel potential therapeutic candidate to treat prostate cancer.

Citing Articles

Unlocking the role of non-coding RNAs in prostate cancer progression: exploring the interplay with the Wnt signaling pathway.

Bu T, Li L, Tian J Front Pharmacol. 2023; 14:1269233.

PMID: 37829301 PMC: 10565042. DOI: 10.3389/fphar.2023.1269233.


MiR-183-5p promotes migration and invasion of prostate cancer by targeting TET1.

Feng Y, Wang K, Qin M, Zhuang Q, Chen Z BMC Urol. 2023; 23(1):116.

PMID: 37430206 PMC: 10334645. DOI: 10.1186/s12894-023-01286-7.


miR-1297 inhibits osteosarcoma cell proliferation and growth by targeting CCND2.

Jiang P, Mao L, Lei X, Luo C, Zhang Y, Zhong X Am J Cancer Res. 2022; 12(7):3464-3478.

PMID: 35968334 PMC: 9360223.


Retracted Article: LncRNA SNHG5 regulates the cell viability and apoptosis of glioma cells by the miR-1297/KPNA2 axis.

Li X, Liu Q, Wang K, Luo W, Liang T, Yuan S RSC Adv. 2022; 10(3):1498-1506.

PMID: 35494689 PMC: 9048252. DOI: 10.1039/c9ra08693e.


Wnt/β-catenin signal transduction pathway in prostate cancer and associated drug resistance.

Wang C, Chen Q, Xu H Discov Oncol. 2022; 12(1):40.

PMID: 35201496 PMC: 8777554. DOI: 10.1007/s12672-021-00433-6.